Susan G. Komen
Career Catalyst Research (CCR)
CCR Grants provide unique opportunities for scientists in the early stages of their careers to achieve research independence. Areas of research include basic, translational/clinical, and disparities in breast cancer outcomes across population groups.
Amount: $150,000 per year for up to 3 years
Deadline: LOI due August 30, 2011
Alliance for Cancer Gene Therapy
2011 Young Investigator Award
Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell
and gene therapy approaches to the treatment of cancer. To this end, ACGT offers its Young Investigator
Award to qualified scientists at the Tenure Track Assistant Professor level.
Amount: $300,000 over 3 years
Deadline: abstract due September 1, 2011
Foundation for Digestive Health and Nutrition
Funderburg Research Scholar Award in Gastric Cancer
The sponsor supports the research of investigators working on novel approaches in the gastric cancer, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.
Amount: $50,000 per year for 2 years
Deadline: September 2, 2011
Concern Foundation
CONquer canCER Now Grant
The sponsor will provide funding for researchers who lack financial support for their first major research project in the areas of cancer genetics, cell biology, and immunology.
Amount: $60,000 for one year
Deadline: LOI by September 8, 2011
The Lustgarten Foundation: Cure Pancreatic Cancer Now
Basic Research Innovator Awards
The Lustgarten Foundation is announcing its "Innovator Awards Program" to fund proposals aimed at supporting novel, "out of the box" research proposals in the area of translational research (bringing the findings of the basic sciences to bear on practical, clinical applications for patients). The Foundation has a particular interest in grants addressing early detection and novel therapeutics but will accept all areas of translational study.
Amount: $100,000 for one year
Deadline: Concept Proposal due September 12, 2011
Prevent Cancer Foundation
Research Grants
The sponsor aims to prevent cancer through scientific research and education, as well as early detection. Grant proposals will be considered in the following categories: basic, clinical, translational, and applied research projects; education programs in cancer prevention; early detection projects; and behavioral intervention projects. Examples of acceptable proposals are: research projects which, if successful, may lead directly to reducing the incidence of cancer; primary and secondary prevention research on all types of cancers; and creative or innovative approaches to cancer prevention research.
Amount: $40,000/year for 2 years
Deadline: September 14, 2011
American Skin Association
Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer
The applicant must have a strong career goal within the field of dermatology and be dedicated to the furtherance of
knowledge concerning melanoma/non-melanoma skin cancer. The research must be focused on new discoveries in the basic and clinical sciences, which should have current or potential impact on the understanding and treatment of melanoma/non-melanoma skin cancer.
Amount: $60,000 for one year
Deadline: September 15, 2011
Hood Foundation
Child Health Research Awards Program
The intent of the Award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding. Research projects must be relevant to child health. Grants support hypothesis-driven clinical, basic science, public health, health services research, and epidemiology projects.
Amount: $150,000 over two years
Deadline: September 16, 2011, noon
Conquer Cancer Foundation of ASCO
Career Development Award
The sponsor provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The awards are intended to support proposals in all oncology subspecialties. Applicants must be a Full Member of the American Society of Clinical Oncology (ASCO) or have submitted a membership application with the grant application.
Amount: $200,000 over 3 years
Deadline: September 28, 2011
Case (Wendy Will) Cancer Fund, Inc.
Grant Program
The sponsor supports innovative researchers. The primary interest is, but not limited to, clinically-related research on cancer. Generally the sponsor does not consider applications which have not been reviewed by one or more major United States funders.
Amount: $30,000 or less for one year
Deadline: October 1, 2011
Pancreatic Cancer Action Network
AACR Research Grants Program
Four grant mechanisms are offered. Funding is available for postdoctoral/clinical research fellows as well as for independent junior and senior researchers. The proposed research must be directly relevant to pancreatic cancer and can be basic, translational, clinical or epidemiological in nature.
Amount: varies by mechanism
Deadline: depending on mechanism, LOI due October 3, 2011 or full application due October 31, 2011
American Cancer Society
Priority Focus in Cancer Control and Prevention Research Program: Health Disparities Research
Sponsor is requesting applications in psychosocial and behavioral research and in health policy and health services (palliative care) research that address cancer health disparities. Within the Cancer Control and Prevention Research Program (one of five research programs in the EG department), meritorious applications focusing on disparity reduction will be funded prior to meritorious applications focusing on other areas in cancer control and prevention research. In order to qualify for the Priority Program, the application must explicitly demonstrate its relevance to cancer disparities and specify how the results of the proposed study can be used to reduce disparities.
Amount: varies by mechanism
Deadline: October 15, 2011
American Cancer Society
Pilot and Exploratory Projects in Palliative Care of Cancer Patients and their Families
This RFA provides funding for investigators performing pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects.
Amount: $60,000 per year
Deadline: October 15, 2011
American Cancer Society
Cancer Control Career Development Awards for Primary Care Physicians
This award is made to support primary care physicians with a rank of instructor to assistant professor who are pursuing an academic career with an emphasis on cancer control. Support is for primary care physicians in supervised programs intended to develop clinical and teaching expertise and the capacity to perform independent research or educational innovation in cancer control.
Amount: $100,000/year for 3 years
Deadline: October 15, 2011
Association for International Cancer Research
Research Grants
AICR awards grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. The sponsor does not support clinical research. The sponsor will consider applications that include some clinical research in a project which is mostly basic or translational. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research are beyond the remit of AICR.Amount: £200,000 over 3 years
Deadline: October 28, 2011
The Lustgarten Foundation: Cure Pancreatic Cancer Now
Correlative Studies Awards Program
The Lustgarten Foundation will fund selected correlative science proposals directly linked to a CTEP sponsored clinical trial of novel therapeutics for pancreatic cancer. These correlative studies will utilize the principles routinely applied to clinical diagnostic tests, including the use of appropriate pharmacodynamic (PD) endpoints, to develop assays that will provide robust and accurate measurements of drug effects in patient specimens. Any investigator eligible to receive support from CTEP and proposing to conduct CTEP-sponsored clinical trial of a novel therapy for pancreatic cancer will be eligible to apply for funding from Lustgarten for support of correlative studies related to the trial.
Amount: Unspecified
Deadline: Applications are accepted on a rolling schedule
All grants are due into the Office of Grants and Contracts five business days prior to the sponsor's deadline for DFCI review and approval prior to submission to the sponsor.